Real-World Evidence Solutions Market Report by Component (Clinical Settings Data, Claims Data, Patient-Powered Data, Pharmacy Data, and Others), Therapeutic Area (Oncology, Immunology, Neurology, Cardiovascular Disease, and Others), End User (Pharmaceutical and Medical Device Companies, Healthcare Payers, Healthcare Providers, and Others), and Region 2025-2033
Market Report I 2025-04-01 I 135 Pages I IMARC Group
The global real-world evidence solutions market size reached USD 1.9 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 3.6 Billion by 2033, exhibiting a growth rate (CAGR) of 7.3% during 2025-2033.
Real-world evidence (RWE) refers to clinical evidence about the use and potential benefits or risks of medical products via real-world data (RWD). It can be produced via different study designs or analyses, including randomized trials, big simple trials, pragmatic trials, and observational studies. It provides insight into real-world treatment patterns in patient groups, including dosing, compliance, adherence, off-label use, and the balance between efficacy and safety. As it can also assist researchers in discovering possible patients and developing correct inclusion criteria for clinical trials, which can help them design better pre-trial studies, there is a rise in the demand for RWE solutions around the world.
Real-World Evidence Solutions Market Trends:
The growing demand for RWE solutions to get precise and clear information about the safety and efficacy of new products represents one of the key factors driving the market. Moreover, there is a rise in the demand for these solutions to detect varied reactions, product subpopulation effects, and product value when utilized by complex and comorbid patients. This, along with the burgeoning healthcare industry, is propelling the growth of the market. Additionally, the growing utilization of advanced analytics and technological solutions in RWE for clinical development, commercialization, speed innovation, and accelerating improvements in healthcare outcomes is positively influencing the market. Besides this, there are various initiatives undertaken by governments of several countries to promote the use of RWE solutions, which provide the efficacy of drugs and vaccines. This, coupled with a shift from volume to value-based care, is offering lucrative growth opportunities to industry investors. Apart from this, the growing adoption of digitalization and patient-centered virtual care is catalyzing the demand for RWE solutions. Furthermore, there is an increase in the prevalence of chronic diseases, such as cancer, obesity, and diabetes, across the globe. In line with this, the rising delays in drug development and the subsequent increase in development costs are bolstering the growth of the market.
Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the global real-world evidence solutions market report, along with forecasts at the global, regional and country levels from 2025-2033. Our report has categorized the market based on component, therapeutic area and end user.
Breakup by Component:
- Clinical Settings Data
- Claims Data
- Patient-Powered Data
- Pharmacy Data
- Others
Breakup by Therapeutic Area:
- Oncology
- Immunology
- Neurology
- Cardiovascular Disease
- Others
Breakup by End User:
- Pharmaceutical and Medical Device Companies
- Healthcare Payers
- Healthcare Providers
- Others
Breakup by Region:
- North America
- United States
- Canada
- Asia-Pacific
- China
- Japan
- India
- South Korea
- Australia
- Indonesia
- Others
- Europe
- Germany
- France
- United Kingdom
- Italy
- Spain
- Russia
- Others
- Latin America
- Brazil
- Mexico
- Others
- Middle East and Africa
Competitive Landscape:
The competitive landscape of the industry has also been examined along with the profiles of the key players being Aetion Inc., Clinigen Limited, Flatiron Health Inc. (Roche Holding AG), ICON plc, International Business Machines Corporation, IQVIA, Optum Inc. (UnitedHealth Group Incorporated), Oracle Corporation, Parexel International Corporation, PPD Inc. (Thermo Fisher Scientific Inc.), Sas Institute Inc. and Syneos Health.
Key Questions Answered in This Report
1.What was the size of the global real-world evidence solutions market in 2024?
2.What is the expected growth rate of the global real-world evidence solutions market during 2025-2033?
3.What are the key factors driving the global real-world evidence solutions market?
4.What has been the impact of COVID-19 on the global real-world evidence solutions market?
5.What is the breakup of the global real-world evidence solutions market based on the component?
6.What is the breakup of the global real-world evidence solutions market based on the therapeutic area?
7.What is the breakup of the global real-world evidence solutions market based on the end user?
8.What are the key regions in the global real-world evidence solutions market?
9.Who are the key players/companies in the global real-world evidence solutions market?
1 Preface
2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
4.1 Overview
4.2 Key Industry Trends
5 Global Real-World Evidence Solutions Market
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast
6 Market Breakup by Component
6.1 Clinical Settings Data
6.1.1 Market Trends
6.1.2 Market Forecast
6.2 Claims Data
6.2.1 Market Trends
6.2.2 Market Forecast
6.3 Patient-Powered Data
6.3.1 Market Trends
6.3.2 Market Forecast
6.4 Pharmacy Data
6.4.1 Market Trends
6.4.2 Market Forecast
6.5 Others
6.5.1 Market Trends
6.5.2 Market Forecast
7 Market Breakup by Therapeutic Area
7.1 Oncology
7.1.1 Market Trends
7.1.2 Market Forecast
7.2 Immunology
7.2.1 Market Trends
7.2.2 Market Forecast
7.3 Neurology
7.3.1 Market Trends
7.3.2 Market Forecast
7.4 Cardiovascular Disease
7.4.1 Market Trends
7.4.2 Market Forecast
7.5 Others
7.5.1 Market Trends
7.5.2 Market Forecast
8 Market Breakup by End User
8.1 Pharmaceutical and Medical Device Companies
8.1.1 Market Trends
8.1.2 Market Forecast
8.2 Healthcare Payers
8.2.1 Market Trends
8.2.2 Market Forecast
8.3 Healthcare Providers
8.3.1 Market Trends
8.3.2 Market Forecast
8.4 Others
8.4.1 Market Trends
8.4.2 Market Forecast
9 Market Breakup by Region
9.1 North America
9.1.1 United States
9.1.1.1 Market Trends
9.1.1.2 Market Forecast
9.1.2 Canada
9.1.2.1 Market Trends
9.1.2.2 Market Forecast
9.2 Asia-Pacific
9.2.1 China
9.2.1.1 Market Trends
9.2.1.2 Market Forecast
9.2.2 Japan
9.2.2.1 Market Trends
9.2.2.2 Market Forecast
9.2.3 India
9.2.3.1 Market Trends
9.2.3.2 Market Forecast
9.2.4 South Korea
9.2.4.1 Market Trends
9.2.4.2 Market Forecast
9.2.5 Australia
9.2.5.1 Market Trends
9.2.5.2 Market Forecast
9.2.6 Indonesia
9.2.6.1 Market Trends
9.2.6.2 Market Forecast
9.2.7 Others
9.2.7.1 Market Trends
9.2.7.2 Market Forecast
9.3 Europe
9.3.1 Germany
9.3.1.1 Market Trends
9.3.1.2 Market Forecast
9.3.2 France
9.3.2.1 Market Trends
9.3.2.2 Market Forecast
9.3.3 United Kingdom
9.3.3.1 Market Trends
9.3.3.2 Market Forecast
9.3.4 Italy
9.3.4.1 Market Trends
9.3.4.2 Market Forecast
9.3.5 Spain
9.3.5.1 Market Trends
9.3.5.2 Market Forecast
9.3.6 Russia
9.3.6.1 Market Trends
9.3.6.2 Market Forecast
9.3.7 Others
9.3.7.1 Market Trends
9.3.7.2 Market Forecast
9.4 Latin America
9.4.1 Brazil
9.4.1.1 Market Trends
9.4.1.2 Market Forecast
9.4.2 Mexico
9.4.2.1 Market Trends
9.4.2.2 Market Forecast
9.4.3 Others
9.4.3.1 Market Trends
9.4.3.2 Market Forecast
9.5 Middle East and Africa
9.5.1 Market Trends
9.5.2 Market Breakup by Country
9.5.3 Market Forecast
10 SWOT Analysis
10.1 Overview
10.2 Strengths
10.3 Weaknesses
10.4 Opportunities
10.5 Threats
11 Value Chain Analysis
12 Porters Five Forces Analysis
12.1 Overview
12.2 Bargaining Power of Buyers
12.3 Bargaining Power of Suppliers
12.4 Degree of Competition
12.5 Threat of New Entrants
12.6 Threat of Substitutes
13 Price Analysis
14 Competitive Landscape
14.1 Market Structure
14.2 Key Players
14.3 Profiles of Key Players
14.3.1 Aetion Inc.
14.3.1.1 Company Overview
14.3.1.2 Product Portfolio
14.3.2 Clinigen Limited
14.3.2.1 Company Overview
14.3.2.2 Product Portfolio
14.3.2.3 Financials
14.3.3 Flatiron Health Inc. (Roche Holding AG)
14.3.3.1 Company Overview
14.3.3.2 Product Portfolio
14.3.4 ICON plc
14.3.4.1 Company Overview
14.3.4.2 Product Portfolio
14.3.4.3 Financials
14.3.4.4 SWOT Analysis
14.3.5 International Business Machines Corporation
14.3.5.1 Company Overview
14.3.5.2 Product Portfolio
14.3.5.3 Financials
14.3.6 IQVIA
14.3.6.1 Company Overview
14.3.6.2 Product Portfolio
14.3.6.3 Financials
14.3.6.4 SWOT Analysis
14.3.7 Optum Inc. (UnitedHealth Group Incorporated)
14.3.7.1 Company Overview
14.3.7.2 Product Portfolio
14.3.8 Oracle Corporation
14.3.8.1 Company Overview
14.3.8.2 Product Portfolio
14.3.8.3 Financials
14.3.8.4 SWOT Analysis
14.3.9 Parexel International Corporation
14.3.9.1 Company Overview
14.3.9.2 Product Portfolio
14.3.9.3 Financials
14.3.10 PPD Inc. (Thermo Fisher Scientific Inc.)
14.3.10.1 Company Overview
14.3.10.2 Product Portfolio
14.3.11 Sas Institute Inc.
14.3.11.1 Company Overview
14.3.11.2 Product Portfolio
14.3.11.3 SWOT Analysis
14.3.12 Syneos Health
14.3.12.1 Company Overview
14.3.12.2 Product Portfolio
14.3.12.3 Financials
14.3.12.4 SWOT Analysis
Figure 1: Global: Real-World Evidence Solutions Market: Major Drivers and Challenges
Figure 2: Global: Real-World Evidence Solutions Market: Sales Value (in Billion USD), 2019-2024
Figure 3: Global: Real-World Evidence Solutions Market Forecast: Sales Value (in Billion USD), 2025-2033
Figure 4: Global: Real-World Evidence Solutions Market: Breakup by Component (in %), 2024
Figure 5: Global: Real-World Evidence Solutions Market: Breakup by Therapeutic Area (in %), 2024
Figure 6: Global: Real-World Evidence Solutions Market: Breakup by End User (in %), 2024
Figure 7: Global: Real-World Evidence Solutions Market: Breakup by Region (in %), 2024
Figure 8: Global: Real-World Evidence Solutions (Clinical Settings Data) Market: Sales Value (in Million USD), 2019 & 2024
Figure 9: Global: Real-World Evidence Solutions (Clinical Settings Data) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 10: Global: Real-World Evidence Solutions (Claims Data) Market: Sales Value (in Million USD), 2019 & 2024
Figure 11: Global: Real-World Evidence Solutions (Claims Data) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 12: Global: Real-World Evidence Solutions (Patient-Powered Data) Market: Sales Value (in Million USD), 2019 & 2024
Figure 13: Global: Real-World Evidence Solutions (Patient-Powered Data) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 14: Global: Real-World Evidence Solutions (Pharmacy Data) Market: Sales Value (in Million USD), 2019 & 2024
Figure 15: Global: Real-World Evidence Solutions (Pharmacy Data) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 16: Global: Real-World Evidence Solutions (Other Components) Market: Sales Value (in Million USD), 2019 & 2024
Figure 17: Global: Real-World Evidence Solutions (Other Components) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 18: Global: Real-World Evidence Solutions (Oncology) Market: Sales Value (in Million USD), 2019 & 2024
Figure 19: Global: Real-World Evidence Solutions (Oncology) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 20: Global: Real-World Evidence Solutions (Immunology) Market: Sales Value (in Million USD), 2019 & 2024
Figure 21: Global: Real-World Evidence Solutions (Immunology) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 22: Global: Real-World Evidence Solutions (Neurology) Market: Sales Value (in Million USD), 2019 & 2024
Figure 23: Global: Real-World Evidence Solutions (Neurology) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 24: Global: Real-World Evidence Solutions (Cardiovascular Disease) Market: Sales Value (in Million USD), 2019 & 2024
Figure 25: Global: Real-World Evidence Solutions (Cardiovascular Disease) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 26: Global: Real-World Evidence Solutions (Other Therapeutic Areas) Market: Sales Value (in Million USD), 2019 & 2024
Figure 27: Global: Real-World Evidence Solutions (Other Therapeutic Areas) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 28: Global: Real-World Evidence Solutions (Pharmaceutical and Medical Device Companies) Market: Sales Value (in Million USD), 2019 & 2024
Figure 29: Global: Real-World Evidence Solutions (Pharmaceutical and Medical Device Companies) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 30: Global: Real-World Evidence Solutions (Healthcare Payers) Market: Sales Value (in Million USD), 2019 & 2024
Figure 31: Global: Real-World Evidence Solutions (Healthcare Payers) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 32: Global: Real-World Evidence Solutions (Healthcare Providers) Market: Sales Value (in Million USD), 2019 & 2024
Figure 33: Global: Real-World Evidence Solutions (Healthcare Providers) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 34: Global: Real-World Evidence Solutions (Other End Users) Market: Sales Value (in Million USD), 2019 & 2024
Figure 35: Global: Real-World Evidence Solutions (Other End Users) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 36: North America: Real-World Evidence Solutions Market: Sales Value (in Million USD), 2019 & 2024
Figure 37: North America: Real-World Evidence Solutions Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 38: United States: Real-World Evidence Solutions Market: Sales Value (in Million USD), 2019 & 2024
Figure 39: United States: Real-World Evidence Solutions Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 40: Canada: Real-World Evidence Solutions Market: Sales Value (in Million USD), 2019 & 2024
Figure 41: Canada: Real-World Evidence Solutions Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 42: Asia-Pacific: Real-World Evidence Solutions Market: Sales Value (in Million USD), 2019 & 2024
Figure 43: Asia-Pacific: Real-World Evidence Solutions Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 44: China: Real-World Evidence Solutions Market: Sales Value (in Million USD), 2019 & 2024
Figure 45: China: Real-World Evidence Solutions Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 46: Japan: Real-World Evidence Solutions Market: Sales Value (in Million USD), 2019 & 2024
Figure 47: Japan: Real-World Evidence Solutions Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 48: India: Real-World Evidence Solutions Market: Sales Value (in Million USD), 2019 & 2024
Figure 49: India: Real-World Evidence Solutions Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 50: South Korea: Real-World Evidence Solutions Market: Sales Value (in Million USD), 2019 & 2024
Figure 51: South Korea: Real-World Evidence Solutions Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 52: Australia: Real-World Evidence Solutions Market: Sales Value (in Million USD), 2019 & 2024
Figure 53: Australia: Real-World Evidence Solutions Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 54: Indonesia: Real-World Evidence Solutions Market: Sales Value (in Million USD), 2019 & 2024
Figure 55: Indonesia: Real-World Evidence Solutions Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 56: Others: Real-World Evidence Solutions Market: Sales Value (in Million USD), 2019 & 2024
Figure 57: Others: Real-World Evidence Solutions Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 58: Europe: Real-World Evidence Solutions Market: Sales Value (in Million USD), 2019 & 2024
Figure 59: Europe: Real-World Evidence Solutions Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 60: Germany: Real-World Evidence Solutions Market: Sales Value (in Million USD), 2019 & 2024
Figure 61: Germany: Real-World Evidence Solutions Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 62: France: Real-World Evidence Solutions Market: Sales Value (in Million USD), 2019 & 2024
Figure 63: France: Real-World Evidence Solutions Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 64: United Kingdom: Real-World Evidence Solutions Market: Sales Value (in Million USD), 2019 & 2024
Figure 65: United Kingdom: Real-World Evidence Solutions Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 66: Italy: Real-World Evidence Solutions Market: Sales Value (in Million USD), 2019 & 2024
Figure 67: Italy: Real-World Evidence Solutions Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 68: Spain: Real-World Evidence Solutions Market: Sales Value (in Million USD), 2019 & 2024
Figure 69: Spain: Real-World Evidence Solutions Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 70: Russia: Real-World Evidence Solutions Market: Sales Value (in Million USD), 2019 & 2024
Figure 71: Russia: Real-World Evidence Solutions Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 72: Others: Real-World Evidence Solutions Market: Sales Value (in Million USD), 2019 & 2024
Figure 73: Others: Real-World Evidence Solutions Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 74: Latin America: Real-World Evidence Solutions Market: Sales Value (in Million USD), 2019 & 2024
Figure 75: Latin America: Real-World Evidence Solutions Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 76: Brazil: Real-World Evidence Solutions Market: Sales Value (in Million USD), 2019 & 2024
Figure 77: Brazil: Real-World Evidence Solutions Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 78: Mexico: Real-World Evidence Solutions Market: Sales Value (in Million USD), 2019 & 2024
Figure 79: Mexico: Real-World Evidence Solutions Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 80: Others: Real-World Evidence Solutions Market: Sales Value (in Million USD), 2019 & 2024
Figure 81: Others: Real-World Evidence Solutions Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 82: Middle East and Africa: Real-World Evidence Solutions Market: Sales Value (in Million USD), 2019 & 2024
Figure 83: Middle East and Africa: Real-World Evidence Solutions Market: Breakup by Country (in %), 2024
Figure 84: Middle East and Africa: Real-World Evidence Solutions Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 85: Global: Real-World Evidence Solutions Industry: SWOT Analysis
Figure 86: Global: Real-World Evidence Solutions Industry: Value Chain Analysis
Figure 87: Global: Real-World Evidence Solutions Industry: Porter's Five Forces Analysis
Table 1: Global: Real-World Evidence Solutions Market: Key Industry Highlights, 2024 and 2033
Table 2: Global: Real-World Evidence Solutions Market Forecast: Breakup by Component (in Million USD), 2025-2033
Table 3: Global: Real-World Evidence Solutions Market Forecast: Breakup by Therapeutic Area (in Million USD), 2025-2033
Table 4: Global: Real-World Evidence Solutions Market Forecast: Breakup by End User (in Million USD), 2025-2033
Table 5: Global: Real-World Evidence Solutions Market Forecast: Breakup by Region (in Million USD), 2025-2033
Table 6: Global: Real-World Evidence Solutions Market: Competitive Structure
Table 7: Global: Real-World Evidence Solutions Market: Key Players
Content is provided by our partners and every effort is made to make Market Report details as clear as possible. If you are not sure the exact content you require is included in this study you can Contact us to double check. To do this you can:
Use the ‘? ASK A QUESTION’ below the license / prices and to the right of this box. This will come directly to our team who will work on dealing with your request as soon as possible.
Write to directly on support@scotts-international.com with details. Please include as much information as possible including the name of report or link so our staff will be able to work on you request.
Telephone us directly on 0048 603 394 346 and an experienced member of team will be on hand to answer.
With the vast majority of our partners we can obtain Sample Pages to support your decision. This is something we can arrange without revealing your personal details.
It is important to note that we will not be able to provide you the exact data or statistics such as Market Size and Forecasts. Sample pages usually confirm the layout or the Categories included in Charts and Graphs, excluding specific data.
To ask for Sample Pages by contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
Whilst we try to make our online platform as easy to use as possible there is always the possibility that a better alternative has not been found in your search.
To avoid this possibility Contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346 and a Senior Team Member can review your requirements and send a list of possibilities with opinions and recommendations.
All prices are set by our partners and should be exactly the same as those listed on their own websites. We work on a Revenue share basis ensuring that you never pay more than what is offered elsewhere.
Should you find the price cheaper on another platform we recommend you to Contact us as we should be able to match this price. You can Contact us though through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
As we work in close partnership with our Partners from time to time we can secure discounts and assist with negotiations, this is part of our personalised service to you.
Discounts can sometimes be arranged for speedily placed orders; multiple report purchases or Higher License purchases.
To check if a Discount is possible please Contact our experienced team through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
Most Market Reports on our platform are listed in USD or EURO based on the wishes of our Partners. To avoid currency fluctuations and potential price differentiations we do not offer the possibility to change the currency online.
Should you wish to pay in a different currency to that advertised online we do accept payments in USD, EURO, GBP and PLN. The price will be calculated based on the relevant exchange rate taken from our National Bank.
To pay in a different above currency to that advertised online please Contact our team and a quotation will be sent within a couple of hours with payment details.
License options vary from Partner to Partner as is usually based on the number of Users that will benefitting from the report. It is very important that License ordered is not breached as this could have potential negative consequences for you individually or your employer.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
The Global Site License is the most comprehensive license available. By selecting this license, the Market Report can be shared with other ‘Allowed Users’ and any other member of staff from the same organisation regardless of geographic location.
It is important to note that this may exclude Parent Companies or Subsidiaries.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
The most common format is PDF, however in certain circumstances data may be present in Excel format or Online, especially in the case of Database or Directories. In addition, for certain higher license options a CD may also be provided.
If you have questions or need clarification about the specific formats we recommend you to Contact us and a detailed explanation will be provided.
Delivery is fulfilled by our partners directly. Once an order has been placed we inform the partner by sharing the delivery email details given in the order process.
Delivery is usually made within 24 hours of an order being placed, however it may take longer should your order be placed prior to the weekend or if otherwise specified on the Market Report details page. Additionally, if details have been not fully completed in the Order process a delay in delivery is possible.
If a delay in delivery is expected you will be informed about it immediately.
As most Market Reports are delivered in PDF format we almost never have to add additional Shipping Charges. If, however you are ordering a Higher License service or a specific delivery format (e.g. CD version) charges may apply.
If you are concerned about additional Shipping Charges we recommend you to Contact us to double check.
We work in Partnership with PayU to ensure payments are made securely in a fast and effortless way. PayU is the e-payments division of Naspers.
Naspers operates in over 133 International Markets and ranks 3rd Globally in terms of the number of e-commerce customers served.
For more information on PayU please visit: https://www.payu.pl/en/about-us
If you require an invoice prior to payment, this is possible. To ensure a speedy delivery of the Market Report we require all relevant company details and you agree to maximum payment terms of 30 days from receipt of order.
With our regular clients deliver of the Market Report can be made prior to receiving payment, however in some circumstances we may ask for payment to be received before arranging for the Market Report to be delivered.
We have specifically partnered with leading International companies to protect your privacy by using different technologies and processes to ensure security.
Everything submitted to Scotts International is encrypted via SSL (Secure Socket Layer) and all personal information provided to Scotts International is stored on computer systems with limited access in controlled environments.
We partner with PayU (https://www.payu.pl/en/about-us) to ensure all credit card payments are made securely in a fast and effortless way.
PayU offers 250+ various payment channels and eWallet services across 4 continents allowing buyers to pay electronically, whether on a computer or a mobile device.